Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Official opening: UFS earmarks R10-million to support national priorities
2006-02-06

 

The University of the Free State (UFS) is to align key areas of its academic and research efforts with national priorities through the introduction of five strategic clusters which would be funded by seedmoney of R10-million in 2006.

Speaking at the Official Opening of the UFS on Friday (3 February 2006), the Rector and Vice-Chancellor, Prof Frederick Fourie, said the academic and research work that will be done in the five strategic clusters would contribute to the development of Mangaung, the Free State, South Africa and Africa.

 “It makes sense to concentrate the university’s human resources, our infrastructure, financial resources and intellectual expertise to ensure that the UFS makes a contribution to the country and the African continent,” Prof Fourie said.

“Strategic clusters will be organised on the basis that these areas of knowledge could become in the short term the flagships of the UFS, meaning those areas where the university currently has or in the very near future is likely to have some competitive advantage,” Prof Fourie said.

According to Prof Fourie, this strategic-cluster approach will be in line with the approach being designed by the National Research Foundation (NRF) to take national priorities into account and would enhance the quality of scholarship at the UFS.

The five strategic areas in which research and academic investment at the UFS will be clustered are the following:

Enabling technologies / Technology for the future;
Food production, quality and food security for Africa;
Development;
Social transformation;
Water resource and ecosystem management;

“Such strategic clusters are understood not only as research areas but as areas that also encompass strong undergraduate and particularly postgraduate teaching and a potentially solid scientific basis for service learning and community service research,” Prof Fourie said.

Within each of these clusters specific niche areas will be identified. Clusters could focus on one or more aspects of a particular discipline or could involve more than one discipline in researching a particular issue.

He said not all academic work and research being done at the UFS would be clustered in this way. Sufficient resources and support have been put in place for general research excellence in the past five years.

“Some of the spin-offs can have an important impact on industrial development, for example in the chemicals industry and may also create a basis for cooperation with provincial, national and international partners,” he said. 

Media release
Issued by: Lacea Loader
Media Representative
Tel:   (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
5 February 2006

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept